Tag: generic drug patents
Olly Steele
20 January 2026
Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Before Launch
Paragraph IV certifications let generic drugmakers challenge brand patents before launch, speeding up access to affordable medicines. Learn how the Hatch-Waxman Act enables this legal battle - and why it's saving billions.
Categories
Archives